{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:01:42Z","timestamp":1787241702181,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/exer.2000.0866","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T11:46:56Z","timestamp":1032176816000},"page":"167-171","source":"Crossref","is-referenced-by-count":62,"title":["Effect of Oral Losartan Potassium Administration on Intraocular Pressure in Normotensive and Glaucomatous Human Subjects"],"prefix":"10.1006","volume":"71","author":[{"given":"Ciro","family":"Costagliola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Verolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Leonarda De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennarfrancesco","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ciancaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exer.2000.0866_RF1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9394(88)90063-3","article-title":"Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open angle glaucoma","volume":"105","author":"Constad","year":"1988","journal-title":"Am. J. Ophthalmol."},{"key":"10.1006\/exer.2000.0866_RF2","series-title":"Proc. X Intern. Congr. Eye Res., Stresa (Italy)","article-title":"Angiotensin converting enzyme inhibitor (SQ 14225) oral administration and intraocular pressure in man","author":"Costagliola","year":"1992"},{"key":"10.1006\/exer.2000.0866_RF3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/112067219500500104","article-title":"Effect of oral captopril (SQ 14225) on intraocular pressure in man","volume":"5","author":"Costagliola","year":"1995","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1006\/exer.2000.0866_RF4","series-title":"Proc. Intern. Symp. on Angiotensin II Antagonism, London (U.K.)","article-title":"Losartan potassium oral administration and intraocular pressure in man","author":"Costagliola","year":"1997"},{"key":"10.1006\/exer.2000.0866_RF5","series-title":"Proc. XIII Intern. Congr. Eye Res. (Paris)","article-title":"Losartan potassium oral administration and intraocular pressure variation in normal and glaucomatous eyes","author":"Costagliola","year":"1998"},{"key":"10.1006\/exer.2000.0866_RF6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00044011-199917040-00009","article-title":"Effect of Losartan potassium oral administration on intraocular pressure in humans","volume":"29","author":"Costagliola","year":"1999","journal-title":"Clin. Drug Invest."},{"key":"10.1006\/exer.2000.0866_RF7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00291-7","article-title":"The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells","volume":"227","author":"Gallinat","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exer.2000.0866_RF8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199651050-00008","article-title":"Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension","volume":"51","author":"Goa","year":"1996","journal-title":"Drugs"},{"key":"10.1006\/exer.2000.0866_RF9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/01.HYP.25.6.1345","article-title":"A randomized, placebo-controlled,, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension","volume":"25","author":"Gradman","year":"1995","journal-title":"Hypertension"},{"key":"10.1006\/exer.2000.0866_RF10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1006\/jmcc.1996.0333","article-title":"Angiotensin II induces apoptosis of adult ventricular myocytes in vitro","volume":"29","author":"Kajstura","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1006\/exer.2000.0866_RF11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0014-4835(88)90036-X","article-title":"Effects of selective dopamine-1-receptor activation on intraocular pressure in man","volume":"47","author":"Karnezis","year":"1988","journal-title":"Exp. Eye Res."},{"key":"10.1006\/exer.2000.0866_RF12","first-page":"644","article-title":"Adrenergic drug effects on aqueous outflow facility following muscle retrodisplacement in cynomolgus monkey","volume":"20","author":"Kaufman","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1006\/exer.2000.0866_RF13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0009-9236(95)90020-9","article-title":"Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP 3174 in humans","volume":"58","author":"Lo","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1006\/exer.2000.0866_RF14","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/archinte.1996.00440160069010","article-title":"Angiotensin II receptor inhibition. A new therapeutic principle","volume":"156","author":"Messerli","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1006\/exer.2000.0866_RF15","first-page":"555","article-title":"Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptors antagonists","volume":"36","author":"Meyer","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1006\/exer.2000.0866_RF16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jop.1996.12.299","article-title":"The renin angiotensin system in the rabbit eye","volume":"12","author":"Ramirez","year":"1996","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1006\/exer.2000.0866_RF17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1681.1997.tb01814.x","article-title":"Angiotensin II-generating system in dog and monkey ocular tissues","volume":"24","author":"Shiota","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1006\/exer.2000.0866_RF18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archopht.1983.01040010096017","article-title":"Blockage of axonal transport in optic nerve induced by elevation of intraocular pressure","volume":"101","author":"Sossi","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1006\/exer.2000.0866_RF19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1006\/bbrc.1995.1229","article-title":"Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells","volume":"207","author":"Tanaka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/exer.2000.0866_RF20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004872-199507001-00001","article-title":"The preclinical basis of the therapeutic evolution of Losartan","volume":"13","author":"Timmermans","year":"1995","journal-title":"J. Hypertension"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483500908662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483500908662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T14:25:36Z","timestamp":1576506336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483500908662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0014483500908662"],"URL":"https:\/\/doi.org\/10.1006\/exer.2000.0866","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}